Cost-effectiveness of sensor-augmented pump therapy in adults with type 1 diabetes in the United States

Value in Health

Volumn 15, Issue 5, 2012, Pages 632-638

  Kamble, Shital ^a,c   Schulman, Kevin A ^a,b   Reed, Shelby D ^a,b  

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c IQVIA   (United States)

Author keywords

insulin; type 1 diabetes mellitus

Indexed keywords

HEMOGLOBIN A1C; INSULIN;

ARTICLE; COMPUTER MODEL; COMPUTER SIMULATION; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST CONTROL; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; DIABETES CONTROL; DIABETIC ANGIOPATHY; DIABETIC RETINOPATHY; EMERGENCY CARE; FEAR; HEALTH CARE COST; HEALTH CARE SYSTEM; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; MEDICAL LITERATURE; OUTPATIENT CARE; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; SENSOR; SENSOR AUGMENTED PUMP THERAPY; TREATMENT OUTCOME; UNITED STATES;

ADULT; COST-BENEFIT ANALYSIS; DIABETES MELLITUS, TYPE 1; FEMALE; FOLLOW-UP STUDIES; HEALTH CARE COSTS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN INFUSION SYSTEMS; MALE; MIDDLE AGED; QUALITY-ADJUSTED LIFE YEARS; TIME FACTORS; UNITED STATES;

EID: 84864609040     PISSN: 10983015     EISSN: 15244733     Source Type: Journal    
DOI: 10.1016/j.jval.2012.02.011     Document Type: Article

References (25)

1. The Diabetes Control and Complications Trial Research Group The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus N Engl J Med 329 1993 977 986
2. D.M. Nathan, P.A. Cleary, J.Y. Backlund Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes N Engl J Med 353 2005 2643 2653
3. R. Retnakaran, J. Hochman, J.H. DeVries Continuous subcutaneous insulin infusion versus multiple daily injections: the impact of baseline A1c Diabetes Care 27 2004 2590 2596
4. J. Pickup, M. Mattock, S. Kerry Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes: meta-analysis of randomised controlled trials BMJ 324 2002 705
5. JDRF CGM Study Group JDRF randomized clinical trial to assess the efficacy of real-time continuous glucose monitoring in the management of type 1 diabetes: research design and methods Diabetes Technol Ther 10 2008 310 321
6. R.M. Bergenstal, W.V. Tamborlane, A. Ahmann Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes N Engl J Med 363 2010 311 320
7. S.N. Davis, E.S. Horton, T. Battelino STAR 3 randomized controlled trial to compare sensor-augmented insulin pump therapy with multiple daily injections in the treatment of type 1 diabetes: research design, methods, and baseline characteristics of enrolled subjects Diabetes Technol Ther 12 2010 249 255
8. Occupational employment statistics US Department of Labor, Bureau of Labor Statistics http://www.bls.gov/oes/home.htm [Accessed July 7, 2010]
9. A.J. Palmer, S. Roze, W.J. Valentine The CORE Diabetes Model: projecting long-term clinical outcomes, costs and cost-effectiveness of interventions in diabetes mellitus (types 1 and 2) to support clinical and reimbursement decision-making Curr Med Res Opin 20 Suppl. 1 2004 S5 S26
10. A.J. Palmer, S. Roze, W.J. Valentine Validation of the CORE Diabetes Model against epidemiological and clinical studies Curr Med Res Opin 20 Suppl. 1 2004 S27 S40
11. The Diabetes Control and Complications Trial Research Group The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus N Engl J Med 329 1993 977 986
12. E.S. Huang, M. O'Grady, A. Basu The cost-effectiveness of continuous glucose monitoring in type 1 diabetes Diabetes Care 33 2010 1269 1274
13. Pharmacy Benefit Management Institute The Takeda Prescription Drug Benefit Cost & Plan Design Survey Report: 2008-2009 A.Z. Scottsdale 2008 Pharmacy Benefit Management Institute, Inc
14. M.R. Gold, J.E. Siegel, L.B. Russell, M.C. Weinstein Cost-Effectiveness in Health and Medicine 1996 Oxford University Press New York
15. S. Roze, W.J. Valentine, K.E. Zakrzewska, A.J. Palmer Health-economic comparison of continuous subcutaneous insulin infusion with multiple daily injection for the treatment of type 1 diabetes in the UK Diabet Med 22 2005 1239 1245
16. N. Cohen, M.E. Minshall, L. Sharon-Nash Continuous subcutaneous insulin infusion versus multiple daily injections of insulin - economic comparison in adult and adolescent type 1 diabetes mellitus in Australia Pharmacoeconomics 25 2007 881 897
17. M. St Charles, P. Lynch, C. Graham, M.E. Minshall A cost-effectiveness analysis of continuous subcutaneous insulin injection versus multiple daily injections in type 1 diabetes patients: a third-party US payer perspective Value Health 12 2009 674 686
18. M.E. St Charles, H. Sadri, M.E. Minshall, S.L. Tunis Health economic comparison between continuous subcutaneous insulin infusion and multiple daily injections of insulin for the treatment of adult type 1 diabetes in Canada Clin Ther 31 2009 657 667
19. E. Cummins, P. Royle, A. Snaith Clinical effectiveness and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes: systematic review and economic evaluation Health Technol Assess 14 2010 iii iv xi-xvi, 1-181
20. C. Currie Multivariate models of health-related utility and the fear of hypoglycaemia in people with diabetes Curr Med Res Opin 22 2006 1523 1534
21. P. Scuffham, L. Carr The cost-effectiveness of continuous subcutaneous insulin infusion compared with multiple daily injections for the management of diabetes Diabet Med 20 2003 586 593
22. US Department of Labor, Bureau of Labor Statistics Employer costs for employee compensation, March 2010 http://www.bls.gov/news.release/archives/ecec- 06092010.pdf [Accessed July 7, 2010]
23. W. Dale, A. Basu, A. Elstein, D. Meltzer Predicting utility ratings for joint health states from single health states in prostate cancer: empirical testing of 3 alternative theories Med Decis Making 28 2008 102 112
24. A.Z. Fu, M.W. Kattan Utilities should not be multiplied: evidence from the preference-based scores in the United States Med Care 46 2008 984 990
25. D.M. Nathan, B. Zinman, P.A. Cleary Modern-day clinical course of type 1 diabetes mellitus after 30 years' duration: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications and Pittsburgh Epidemiology of Diabetes Complications experience (1983-2005) Arch Intern Med 169 2009 1307 1316